Last month the FDA approved a new treatment for sickle cell disease, the first medical therapy to use CRISPR gene editing technology. It works by identifying the gene or genes causing the disorder, modifying those genes and then returning them to the patient’s body.
There are now two gene therapies offered by pharmaceutical companies for sickle cell disease: Casgevy from Vertex Pharmaceuticals and CRISPR Therapeutics, and Lyfgenia from BlueBird Bio. But prices for these one-time treatments are steep: Casgevy costs $2.2 million per patient and Lyfgenia $3.1 million.
Both promise a full cure, which would be life-changing for patients with this debilitating condition. Over 100,000 Americans, mostly of African descent, have sickle cell disease.
This milestone raises more questions: What will be the next disease that CRISPR can help cure? And is it possible to reduce the costs of gene therapy treatments?
Ira talks with Dr. Fyodor Urnov, professor of molecular and cell biology and scientific director of technology and translation at the Innovative Genomics Institute, based at the University of California, Berkeley, about the future of CRISPR-based cures.
Transcripts for this segment will be available the week after the show airs on sciencefriday.com.
To stay updated on all things science, sign up for Science Friday's newsletters.
696: ‘Mysterious’ Canine Illness: What Dog Owners Should Know
694: An App For People Of Color To Rate Their Birthing Experiences | How Different Animals See
697: NASA Opens Canister With Asteroid Sample | ADHD Prescription Rates Spiked During The Pandemic
693: AI Helps Find Ancient Artifacts In The Great Lakes | An Artist Combines Indigenous Textiles With Modern Tech
691: When The ‘Personal’ Computer Turned 30
690: How The Moon Transformed Life On Earth, From Climate to Timekeeping
692: From Scans To Office Visits: How Will AI Shape Medicine?
689: Rhesus Monkey Cloned With Modified Approach Has Survived Into Adulthood
688: 3,000 Types Of Brain Cells Categorized In Massive Brain Cell Atlas
685: Brain ‘Organoids’: Lab-Grown Cell Clusters Model Brain Functions
687: The Lasting Allure Of Shackleton’s ‘Endurance’
684: How Close Are We To Answers About Aliens?
686: NASA Delays Crewed Moon Missions | Top Technologies To Watch In 2024
683: To Get Ready For Mars, NASA Studies How The Body Changes In Space
682: Science Journalism Is Shrinking–Along With Public Trust In Science
680: (Part 2) Endangered Species Act At 50: Orchids And Red Wolves
679: (Part 1) Endangered Species Act at 50: Hawaiian Land Snails
681: Solar Activity Flares Up In 2024 | Underground Hydrogen Reserves And Clean Energy
678: SciFri Reads ‘The Alchemy Of Us’
677: SciFri Reads ‘The Kaiju Preservation Society’
Create your
podcast in
minutes
It is Free
The Modern West
Voices of Misery Podcast
House of Whimsical Terror
Dairyland Frights
Stuff You Should Know
Timcast IRL